Determination of the solution structures of conantokin-G and conantokin-T by CD and NMR spectroscopy by Skjaerbaek, N et al.
Determination of the Solution Structures of Conantokin-G and
Conantokin-T by CD and NMR Spectroscopy*
(Received for publication, June 18, 1996, and in revised form, September 5, 1996)
Niels Skjærbæk, Katherine J. Nielsen, Richard J. Lewis, Paul Alewood‡, and David J. Craik§
From The Centre for Drug Design and Development, The University of Queensland, Brisbane, Qld 4072, Australia
Conantokin-G and conantokin-T are two paralytic
polypeptide toxins originally isolated from the venom of
the fish-hunting cone snails of the genus Conus. Conan-
tokin-G and conantokin-T are the only naturally occur-
ring peptidic compounds which possess N-methyl-D-as-
partate receptor antagonist activity, produced by a
selective non-competitive antagonism of polyamine re-
sponses. They are also structurally unusual in that they
contain a disproportionately large number of acid labile
post-translational g-carboxyglutamic acid (Gla) resi-
dues. Although no precise structural information has
previously been published for these peptides, early
spectroscopic measurements have indicated that both
conantokin-G and conantokin-T form a-helical struc-
tures, although there is some debate whether the pres-
ence of calcium ions is required for these peptides to
adopt this fold. We now report a detailed structural
study of synthetic conantokin-G and conantokin-T in a
range of solution conditions using CD and 1H NMR spec-
troscopy. The three-dimensional structures of conan-
tokin-T and conantokin-G were calculated from 1H
NMR-derived distance and dihedral restraints. Both co-
nantokins were found to contain a mixture of a- and 310
helix, that give rise to curved and straight helical con-
formers. Conantokin-G requires the presence of diva-
lent cations (Zn21, Ca21, Cu21, or Mg21) to form a stable
a-helix, while conantokin-T adopts a stable a-helical
structure in aqueous conditions, in the presence or ab-
sence of divalent cations (Zn21, Ca21, Cu21, or Mg21).
Conantokin-G (con-G)1 and conantokin-T (con-T) are highly
conserved polypeptides originally isolated from the venoms of
piscivorous cone snails Conus geographus (1) and Conus tulipa
(2), respectively. These polypeptides are just two components in
the very complex venom that these snails have developed for
rapidly immobilizing their fast moving prey (3). Evidence indi-
cates that both con-G and con-T possess N-methyl-D-aspartate
receptor (NMDA receptor) antagonist activity, produced by a
selective non-competitive antagonism of polyamine enhance-
ment of NMDA receptor agonist activity (4–7). To date, these
are the only naturally occurring peptides known to have this
property. Con-G and con-T are also structurally unusual, in
that they lack the disulfide motifs commonly found in conotoxin
peptides and instead contain a high proportion of the base-
stable but acid-labile g-carboxyglutamic acid (Gla) residue (8,
9). Gla residues were originally identified in the vitamin K-de-
pendent blood-clotting factors including prothrombin. Subse-
quently they were found in other vertebrate proteins such as
osteocalcin (calcium-binding protein) (10, 11) and have been
implicated in Ca21 binding (12, 13). The discovery of Gla resi-
dues in several Conus peptides has established that this post-
translational modification has a much wider phylogenetic dis-
tribution than previously thought (14).
Although no precise structural information has yet been
published for these peptides using either high field NMR or
x-ray techniques, previous CD spectroscopic measurements
have indicated that con-G and con-T are folded in a stable
a-helical conformation (7, 9). However, there is some dispute
over whether these structures are stabilized by Ca21 (4, 7) and
furthermore, whether Ca21 is essential to the biological func-
tion of the conantokin peptides (7). To investigate this intrigu-
ing problem we have synthesized con-G and con-T using Boc
chemistry and investigated their solution structures in detail
by CD and 1H NMR spectroscopy. The effects of the solution
environment including pH, monovalent cation (K1), divalent
cations (Zn21, Ca21, Cu21, and Mg21), EDTA, and TFE on the
structures of con-G and con-T were monitored by CD spectros-
copy. Both peptides were also examined under several condi-
tions by 1H NMR spectroscopy and their three-dimensional
structures were calculated based on the NMR-derived
restraints.
EXPERIMENTAL PROCEDURES
Chemicals and Reagents
All coded Boc-L-amino acids and reagents used during chain assem-
bly were peptide synthesis grade supplied by Auspep Ptd. Ltd.
(Parkville, Victoria). Acetonitrile (HPLC grade) was purchased from
Laboratory Supply Pty. Ltd. (Coorparoo, Queensland). Deionized water
was used throughout and prepared by a Milli-Q water purification
system (Millipore, Waters). Screw-cap glass peptide synthesis reaction
vessels (10 ml) with a sintered glass filter were obtained from Embel
Scientific Glassware (Queensland). An all-Kel-F apparatus (Peptide
Institute, Osaka, Japan) was used for HF cleavage. Argon, helium, and
nitrogen were all ultrapure grade (CIG, Australia).
Peptide Synthesis
The sequences of the two conantokins are: conantokin-G, Gly-Glu-G-
la-Gla-Leu-Gln-Gla-Asn-Gln-Gla-Leu-Ile-Arg-Gla-Lys-Ser-Asn-NH2;
and conantokin-T, Gly-Glu-Gla-Gla-Tyr-Gln-Lys-Met-Leu-Gla-Asn-
Leu-Arg-Gla-Ala-Glu-Val-Lys-Lys-Asn-Ala-NH2. The linear conanto-
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The atomic coordinates and structure factors (codes 1ONU and 1ONT)
have been deposited in the Protein Data Bank, Brookhaven National
Laboratory, Upton, NY.
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1 The abbreviations used are: con-G, conantokin-G; con-T, conan-
tokin-T; NMR, nuclear magnetic resonance; MS, mass spectrometry;
DQF-COSY, double quantum filtered correlated spectroscopy; TOCSY,
total correlated spectroscopy; NOESY, nuclear Overhauser enhance-
ment spectroscopy; Boc, tert-butoxycarbonyl; HF, hydrogen fluoride;
Gla, g-carboxyglutamic acid; TFE, 2,2,2-trifluoroethanol; NMDA, N-
methyl-D-aspartate; RMSD, root mean square deviation; deg, degree.
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kins were assembled manually using solid phase methodology with Boc
chemistry (15). Both peptides were assembled on p-methylbenzhy-
drylamine-resinzHCl on a 0.2 mmol scale. The following side chain
protected amino acids were employed: Asn(xanthyl), Lys(2-chloroben-
zyloxycarbonyl), Glu(g-cyclohexyl), Arg(p-toluenesulfonyl), Ser(benzyl),
Gln(xanthyl), and Gla(g-cyclohexyl)2. A 4-fold excess of Boc amino acids
was used based on the original substitution of p-methylbenzhy-
drylamine-resinzHCl. Boc-L-Gla(g-cyclohexyl)2-OHzDCHA was coupled
with a 1.25 mol excess. Boc-Gla(g-cyclohexyl)2 was synthesized as de-
scribed previously (8). All amino acids were activated using 2-(1H-
benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate
(0.5 M in dimethylformamide) and N,N-diisopropylethylamine and cou-
pled for 10 min, except for Boc-Gla(g-cyclohexyl)2 which was coupled for
60 min. Boc protecting groups were removed using 100% trifluoroacetic
acid and the peptides were cleaved from the resin using HF.
Con-G—The peptide resin (415 mg, 94.3 mmol) was treated with HF
(9 ml) in the presence of p-cresol (1 ml) at 25 °C for 2 h. Crude peptide
was precipitated with cold ether, washed with cold ether, then extracted
into 20% acetic acid and lyophilized to yield 201 mg (86%) of crude
con-G. The crude peptide was purified on a conventional reverse-phase
Vydac C18 silica preparative column using a linear gradient (0–80% B)
over 80 min at a flow of 8 ml/min. Solvent A was 0.1% aqueous triflu-
oroacetic acid, solvent B was 90% acetonitrile/water containing 0.09%
trifluoroacetic acid. Sample absorbance was recorded at 230 nm. Highly
pure fractions were collected and lyophilized and pure con-G was fur-
ther lyophilized 3 times from deionized water. ES-MS: [M 1 H]1 2264.6
(calculated 2265.2). Amino acid analysis after hydrolysis in 6 M HCl at
105 °C for 24 h: Asx 2.43 (2), Glx 8.28 (8), Ser 0.90 (1), Gly 0.91 (1), Arg
1.00 (1), Ile 0.73 (1), Leu 1.83 (2), Lys 0.93 (1).
Con-T—This peptide was prepared in a similar fashion to con-G to
yield 126 mg (51%). ES-MS: [M 1 H]1 2684.0 (calculated 2684.9).
Amino acid analysis after hydrolysis in 6 M HCl at 105 °C for 24 h: Ala
2.01 (2), Asx 2.21 (2), Glx 7.20 (7), Gly 0.98 (1), Val 1.05 (1), Met 0.93 (1),
Tyr 1.07 (1), Arg 1.03 (1), Leu 1.90 (2), Lys 3.10 (3).
Mass Spectrometry
Mass spectra were acquired on a PE-SCIEX API III triple quadrupole
mass spectrometer equipped with an ionspray atmospheric pressure
ionization source. Mass spectra were typically acquired in 5–15 min on
an Apple Macintosh IIfx computer and processed using the software
package MacSpec (Sciex, Toronto, Canada). Interpretation of the spec-
tra was aided by MacBiospec (Sciex, Toronto, Canada).
Peptide Authentication
Venom was isolated from the dissected venom ducts of individual C.
geographus and C. tulipa collected on the Great Barrier Reef, Australia
(16). Soluble venom components were extracted with 30% acetonitrile/
water acidified with 0.1% trifluoroacetic acid, freeze-dried, and stored
at 220 °C. Venom was redissolved in 5% acetonitrile/water acidified
with 0.1% trifluoroacetic acid at '1 mg/ml prior to HPLC purification.
Comparative HPLC analyses were performed on the native peptides,
the synthetic peptides, and a mixture of native and synthetic peptides
(1:1). HPLC analyses were performed on an analytical HPLC system
(ABI 140B dual syringe pump gradient HPLC system) using a Vydac
C18 5-mm column (2.1 3 250 mm). Chromatograms were achieved using
a linear gradient of 0–80% B over 160 min at a flow rate of 1 ml/min.
Solvent A was 0.1% aqueous trifluoroacetic acid, solvent B was 90%
acetonitrile/water acidified with 0.09% trifluoroacetic acid. Synthetic
samples of con-G and con-T both co-eluted with the native samples
(data not shown) which confirmed that the synthetic and native mate-
rials were identical.
Cation Removal
Preparative HPLC was performed immediately on a calcium loaded
con-G sample (CaCl2, 6.5 mM) following CD analysis. CD analysis of the
repurified peptide showed no helix formation to be present. This is
indicated by the lack of minima at 208 and 222 nm (data not shown).
Thus HPLC chromatography under acidic conditions is sufficient to
remove Ca21 bound to con-G.
CD Studies
CD spectra were obtained using a Jasco spectrometer (J-710) with a
0.1-cm path length cuvette at 20 °C. Both peptides were dissolved in a
10 mM phosphate buffer (pH 7.4) at a 75 mM concentration, for all
experiments. The secondary structure was estimated by analysis of the
spectrum between 190 and 250 nm. Mean residue ellipticity [u]MR is
expressed in degrees-square centimeter per decamole ((degzcm2)/dmol).
Experimental estimates of helical contents were determined from the
[u]222 measurements. An estimate of helical content was determined
using an equation developed by Chakrabartty et al. (17) (240,000
(1–2.5/n); n 5 number of residues), where 240,000 and 0 (degzcm2)/dmol
are the values for 100% and 0% a-helix, respectively. This equation is
used only as a qualitative estimate of peptide helicity.
NMR Spectroscopy
All NMR spectra were recorded on a Bruker ARX 500 spectrometer
equipped with a z-gradient unit. Peptide concentrations were 2 mM.
Spectra of con-G were obtained in 95% H2O, 5% D2O with no CaCl2 (pH
5.5), 1:1 (pH 5.5) and 5:1 (pH 3.5 and 5.5) ratios of CaCl2 to peptide, and
in 33% TFE. Spectra of con-T were obtained in 95% H2O, 5% D2O with
no CaCl2 (pH 5.5) and a 5:1 (pH 5.5) ratio of CaCl2 to peptide, and in
33% TFE. 1H NMR spectra recorded were DQF-COSY (18), NOESY (19,
20) with mixing times of 100–300 ms and TOCSY (21) with a mixing
time of 65 ms. All spectra were recorded at 280 K, except for some
additional spectra at 298 K. Spectra were run over 6024 Hz with 4 K
data points, 400–600 free induction decays, 16–64 scans, and a recycle
delay of 1 s (1.5 s for DQF-COSY). In NOESY and TOCSY spectra, the
solvent was suppressed using the WATERGATE sequence (22). Spectra
were processed using UXNMR. Free induction decays were multiplied
by a polynomial function and apodized using a 60 or 90 ° shifted sine-
bell function in both dimensions prior to Fourier transformation. Base-
line correction using a fifth polynomial was applied and chemical shift
values were referenced externally to 4,4-dimethyl-4-silapentane-1-sul-
fonate at 0.00 ppm. 3JNH-Ha coupling constants were measured from
high resolution one-dimensional spectra (32 K) and compared to those
obtained from the DQF-COSY spectra which were strip transformed to
8K 3 1K and extracted using the Lorentzian line-fitting routine in the
program Aurelia (Bruker GMBH).
Distance Restraints and Structure Calculations
Peak volumes in NOESY spectra were classified as strong, medium,
weak, or very weak corresponding to upper bounds on interproton
distances of 2.7, 3.5, 5.0, or 6.0 Å, respectively. Lower distance bounds
were set to 1.8 Å. Appropriate pseudoatom corrections (23) were made
and distances of 1.5 Å and 2.0 Å were added to the upper limits of
restraints involving methyl and phenyl protons, respectively. 3JNH-Ha
coupling constants were used to determine f dihedral angle restraints
(24).
Structures were calculated (coordinates have been deposited with the
Brookhaven Protein Databank) using the simulated annealing protocol
in X-PLOR (25, 26) version 3.1 using the geometric forcefield, parallh-
dg.pro. Starting structures were generated using random (f, c) dihe-
dral angles and energy minimized (500 steps) to produce structures
with correct local geometry. The structures were subjected to a total of
30 ps of high temperature molecular dynamics before cooling and en-
ergy minimization (1000 steps). Structure refinements were performed
using energy minimization (2000 steps) under the influence of the
CHARMM forcefield (27).
Data Analysis
Structures were compared using pairwise and average RMSDs for
the Ca, C, and N atoms (X-PLOR version 3.1) and by calculating
angular order parameters for the backbone dihedral angles (28, 29).
Structure visualization was performed using INSIGHT II (Biosym
Technology Inc.).
RESULTS
Circular Dichroism Spectroscopy—CD spectra were used as
a qualitative gauge of peptide secondary structure. The CD
spectra of con-G and con-T both exhibit minima at 208 and 222
nm at high concentrations of CaCl2 (9.2 and 4.5 mM, respec-
tively), which is the characteristic signature for a-helix. In-
creasing the CaCl2 concentration further did not enhance the
a-helix content in either peptide, nor did the addition of 50%
TFE to the CaCl2 (9.2 mM) solution of con-G (Fig. 1A). For
con-G, there is clearly a CaCl2 concentration dependence. In
the absence of CaCl2 almost no helical structure was observed
(7%) but on increasing the CaCl2 concentration, the percentage
of helical structure rose steadily to a maximum of 45% (Fig.
1A). In contrast, when this experiment was performed with
con-T, no CaCl2 concentration dependence was observed. In-
stead, con-T showed a high degree of helical content (50%) in
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buffer solution alone (Fig. 1B). Although the addition of CaCl2
did not affect the percentage of a-helix present in con-T, the
addition of 50% TFE to a 4.5 mM CaCl2 solution increased the
a-helical content to 63%. The same result was obtained in 100%
TFE (Fig. 1B).
As the conantokin peptides apparently bind to, or affect
allosterically, the putative combined polyamine/Mg21 binding
site on the NMDA receptor (30, 31), it was of interest to deter-
mine the effects of Mg21 on the structure of con-G and con-T
and to explore the possibility that other positively charged ions
could stabilize the structures in the same manner as CaCl2.
The CD spectra showing the effects of cation concentration on
con-G are given in Fig. 1C. As anticipated, monovalent potas-
sium ion did not stabilize the structure of con-G. On the other
hand, Cu21 stabilizes the peptide as efficiently as Ca21. Most
striking were the effects of Mg21 and Zn21, which provided
greater stabilization to the con-G structure than Ca21, with
estimated a-helix contents of 68 and 69%, respectively. As seen
in Fig. 1D, different cations did not significantly affect the
helical content of con-T, which was estimated to be 50%.
CD spectra showing the effects of the addition of EDTA to a
fixed concentration of peptide (con-G) and CaCl2 are given in
Fig. 1E. In this experiment, the degree of a-helix present for
con-G in CaCl2 is substantially decreased by the presence of
EDTA. This indicates that EDTA chelates some of the CaCl2.
However, the minimum a-helix content is greater than that
calculated for con-G in buffer alone, even when a large excess of
EDTA (20 mM) is added to the CaCl2 solution. Furthermore, it
was shown that addition of 3.0 mM EDTA to a con-G solution
with no CaCl2 present had no effect on the peptide structure.
The CD results show that the structure of con-T is predom-
inantly helical in aqueous buffer and more so in TFE. Cations
such as Ca21, Cu21, K1, Mg21, and Zn21 have no significant
effect on the helix content of this peptide (Fig. 1D). In contrast,
the structure of con-G, which is not highly helical in buffer, is
greatly affected by the presence of Ca21, presumably with the
Gla residues being involved in the Ca21-binding interaction.
For con-G, the degree of helicity correlated to the amount of
Ca21 present. In the presence of excess EDTA, there is appar-
ently substantial Ca21 which remains chelated to the peptide,
either inaccessible to, or in equilibrium with, EDTA. The CD
studies show that con-G is selective for divalent cations, with
monovalent cations having little influence on the structure of
this peptide. No cation selectivity was observed for con-T. This
study provides evidence that Mg21 and Zn21 induce greater
helical content than Ca21 and Cu21 in con-G.
NMR Spectroscopy
Chemical Shift Assignment—Due to the large number of
residues with similar spin-types the two-dimensional spectra of
con-G and, to a lesser extent con-T, are severely overlapped
under the conditions used. Despite this, assignment was pos-
sible by a careful analysis of NOESY, TOCSY, and DQF-COSY
spectra (23). An example of the NOESY spectrum of con-G in
H2O showing the sequential assignment is given in Fig. 2. The
complete chemical shift assignments of con-G and con-T are
supplied as supplementary material.
Secondary Ha Shifts—The deviations of Ha chemical shifts
from their random coil values provide information on peptide
backbone structure (23, 32). For con-G in H2O, there are some
large negative secondary Ha shifts indicative of a-helix from
tions. B, CD spectra of con-T obtained at different CaCl2 concentrations.
C, CD spectra of con-G obtained with different metal ions. D, CD
spectra of con-T obtained with different metal ions. E, CD spectra of
con-G with fixed CaCl2 concentration and different EDTA concentrations.
FIG. 1. CD spectra of con-G and con-T under different condi-
tions. A, CD spectra of con-G obtained at different CaCl2 concentra-
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Asn8 to the C terminus (Fig. 3). The magnitude of the second-
ary shift is greatest in region 9–13. The addition of TFE did not
alter the pattern of secondary shift, but greatly enhanced the
magnitude of secondary shift for each residue, indicating that
the a-helix is stabilized over the entire peptide. Similarly, the
addition of CaCl2 to con-G accentuated the negative secondary
shifts. At pH 3.5, the secondary shifts of residues 5–6 and 8–9
are enlarged, while at pH 5.5, a-helix is further stabilized over
the whole peptide. This is consistent with the Ca21-induced
secondary structure stabilization. Furthermore, since the helix
content increased at a higher pH, this suggests that the Ca21
binds to the negatively charged Gla side chains.
The large negative secondary Ha shifts of con-T (Fig. 4)
indicate that this peptide is extremely helical, even in H2O
(residues 3–21) and more so in TFE (residues 2–21). The effects
of Ca21 on the Ha shifts were minimal, supporting the CD data
which clearly indicated that there was no overall structural
stabilization in this case. However, an exception to this is the
secondary Ha shift of Gla10, which is shifted to a positive value,
in the presence of Ca21 at pH 5.5. It is noteworthy that this is
also observed for con-G, under the same conditions. Although
this implies helix disruption, it may instead be due to an
underestimate of the random coil shift of Gla (this is not avail-
able in the literature and the value for Glu was used in its
place).
NOEs—A summary of the observed sequential and medium-
range NOEs for con-G is given in Fig. 5. No long range NOEs
were detected under any of the conditions used. Although many
medium-range NOEs (Ha-Hbi13, Ha-HNi12, and HaHbi13)
were present, consistent with a-helical secondary structure,
the peak overlap meant that it was not possible to detect many
NOEs that may be expected based on the extent of a-helix
deduced from the chemical shift data. This is most evident in
the data collected at pH 5.5 in the presence of Ca21. In this
case, the combined effects of large line widths and peak overlap
were deleterious to spectral quality, resulting in few observable
connectivities in the NH-Ha region. Increasing the tempera-
ture to 298 K sharpened the line widths, however, the accom-
panying decrease in correlation time resulted in low NOE in-
tensities. Despite this, from decreases in the Ha-NHi11/NH-
NHi11 ratios, and from the observation of key medium-range
NOEs, it is clear that the a-helical content, present over the
region encompassed by residues 5–17 in the absence of CaCl2,
increased in the presence of CaCl2 to incorporate the entire
peptide. In particular, the strengths of the non-overlapped
Ha-Hbi13 NOEs, i.e. from Leu
5-Asn8 and Gla10-Gla14 increase
significantly in the presence of CaCl2 at pH 5.5. At pH 3.5 and
in the presence of CaCl2 there is less difference in NOE
strengths compared with con-G at pH 5.5, providing further
FIG. 2. NOESY spectrum of con-G in the NH-Ha region. The
NH-Ha region of the NOESY spectrum (mixture 5 300 ms) of con-G in
H2O (T 5 280 K; pH 5.5) showing the sequential connectivities.
FIG. 3. Secondary Ha shifts for
con-G under different conditions.
Secondary Ha shifts in ppm (y axis), cal-
culated using the random coil shifts of
Merutka et al. (37) for (A) con-G in H2O
and TFE and (B) con-G with 5:1 CaCl2 at
pH 3.5 and 5.5. The Glu random coil Ha
chemical shift was substituted for that of
Gla which is not known.
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support that the Gla side chains need to be charged for optimal
helix stability and Ca21 chelation.
The two-dimensional spectra of con-T were more dispersed in
the NH region than those of con-G. Consequently, it was pos-
sible to observe many more NOEs (Fig. 6). In H2O, the large
number of characteristic Ha-NHi13, Ha-NHi14, Ha-NHi12, and
Ha-Hbi13 NOEs, medium-strong NH-NHi11 and medium Ha-
NHi11 NOEs show that con-T adopts a-helix from residues 2 to
21. The helix enhancement in the presence of TFE is suggested
by the slightly weaker Ha-NHi11 relative to NH-NHi11 NOEs.
However, the addition of TFE caused a reduction in NH shift
dispersion so that many connectivities are not detectable.
3JNH-Ha Coupling Constants and Slow Exchange Data—The
3JNH-Ha coupling constant and NH slow exchange data aug-
ment the NOE information. Over the range of solution condi-
tions, it was possible to obtain 3JNH-Ha data for all residues of
both peptides. Consistent with well defined a-helix, all meas-
urable 3JNH-Ha coupling constants are low (,6 Hz) in con-T
apart from that of Asn20. Similarly, for con-G, all 3JNH-Ha
coupling constants are low except for Ser16 and Asn17 which are
only slightly larger (,7 Hz), reflecting some degree of confor-
mational averaging at the C terminus. The extent and stability
of helix is further demonstrated by the large proportion (13/20)
of NH protons of con-T which were observed to be slowly ex-
changing in aqueous solution, despite the relatively high pH.
Similarly, several (7/16) of the NH protons of con-G in CaCl2
also exchanged slowly with solvent.
Three-dimensional Structure of Conantokin Peptides
The secondary structure analysis indicates that con-G adopts
transient a-helix in aqueous solution which is stabilized by the
presence of Ca21, although the CD analysis indicates that
other divalent cations will suffice or even improve helix stabi-
lization. In contrast, con-T forms a stable a-helix in aqueous
solution in the absence or presence of divalent counterions. The
conditions needed for these peptides to adopt what is presum-
ably their inherently preferred conformational state are differ-
ent, however, the qualitative study described above suggests
that their three-dimensional structures are similar. This may
also be inferred from high sequence identity in the N-terminal
region and from the similarity of their biological activity. A quan-
titative comparison of con-G and con-T based on the computa-
tion of their three-dimensional structures is described below.
Three-dimensional Structure of Conantokin-G—A total of
161 distance restraints (58 intra residual, 60 sequential, and 43
medium range) and 14 dihedral restraints were used in the
calculation of 30 structures. Of these structures 18 had no NOE
violations greater than 0.2 Å and no dihedral violations greater
than 3° and were chosen to represent the structure of con-G.
The structures satisfy the experimental and empirical criteria
as the average deviations from ideal covalent geometry and
experimental restraints are low and the potential-energy and
restraint energy contributions are favorable (Table I). While
the backbone pairwise RMSD is high over the whole molecule,
the RMSDs over each half are much lower (Table I), suggesting
that the helix has some flexibility. This can also been seen from
the backbone angular order parameters and RMSD values for
individual residues shown in Fig. 7A. The angular order pa-
rameters are high over residues 2–15, indicating consistency in
local geometry among the structures. As is usual with linear
peptides, there are elevated RMSDs at the termini consistent
with some helix fraying. The RMSD values are lowest in two
FIG. 4. Secondary Ha shifts for con-T under different condi-
tions. Secondary Ha shifts in ppm (y axis), calculated using the random
coil shifts of Merutka et al. (37) for con-T in H2O, CaCl2, and TFE. The
Glu random coil Ha chemical shift was substituted for that of Gla which
is not known.
FIG. 5. Sequential NOEs for con-G under different conditions.
A summary of sequential NOEs for con-G in (A) H2O, pH 5.5; (B) 5:1
CaCl2, pH 3.5; and (C) 5:1 CaCl2, pH 5.5. Thickness of the bars repre-
sent the strength of the NOE connectivities and unshaded bars repre-
sent peak overlap. Also shown are medium range NOE connectivities,
3JNH-Ha coupling constants and slow exchange NH protons (filled cir-
cles). 3JNH-Ha coupling constants were unobtainable in the 5:1 CaCl2:
peptide solution (pH 5.5), due to large line widths. Slow exchange data
were obtained only for B, as the data from which 30 structure restraints
were obtained.
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sections of the peptide (residues 5–6 and 9–14), but elevated at
residues 7–8.
It is evident from a series of backbone superimpositions (Fig.
8) over particular regions, that the helix of con-G is highly
defined over segments of up to 8 residues. Superimpositions of
the middle segment of the peptide highlights the good defini-
tion but leaves an exaggerated impression of frayed termini.
However, superimpositions in regions around the N or C ter-
minus show clearly that helix is relatively well defined at both
termini (Fig. 8). This is upheld by analysis of the backbone f-c
coordinates which shows that all residues lie in the a-region of
the Ramachandran plot. While the individual three-dimen-
sional structures of con-G each consist of unbroken helix, few of
the helices are linear, with most having some form of kink or
curvature. This implies that either the NMR data are not
sufficient to define the relative orientations of sections of the
helix, or that the long helix has genuine flexibility. The high
degree of curvature observed in most of our structures is not
surprising, as this is commonly observed for amphipathic hel-
ices in solution (33, 34). Analysis of the backbone H-bonds
shows that all structures contain a mixture of i,i13, and i,i14
interactions, consistent with 310 and a-helix, respectively,
where the 310 helix component consists of approximately 38%
of the total backbone H-bonds.
Three-dimensional Structure of Conantokin-T—A set of
17/30 structures was chosen to represent con-T, based on the
FIG. 6. Sequential NOEs for con-T
under different conditions. A sum-
mary of sequential NOEs for con-T in (A)
H2O, pH 5.5; and (B) 30% TFE. Thickness
of the bars represent the strength of the
NOE connectivities and unshaded bars
represent peak overlap. Also shown are
medium range NOE connectivities, 3JNH-
Ha coupling constants and slow exchange
NH protons (filled circles). 3JNH-Ha cou-
pling constants and slow exchange NH
protons were not obtained for B due to
large line widths and weak signals in
TOCSY experiment.
TABLE I
Geometric and energetic statistics for the conantokin structures
Conantokin-G Conantokin-T
Average RMSD to mean structure 1.68 Å 1.86 Å
Pairwise RMSD for Ca, N, C atoms
All residues 2.46 Å 1.71 Å
N terminus 1.22 Å (residues 2–9) 0.67 Å (residues 2–10)
C terminus 0.85 Å (residues 10–17) 0.86 Å (residues 13–20)
RMSDs from distance restraints 0.010 6 0.004 Å 0.016 6 0.006 Å
RMSDs from dihedral restraints 0.11 6 0.12° 0.17 6 0.13°
RMSDs from idealized geometry
Bonds (Å) 0.010 6 0.001 0.009 6 0.001
Angles (°) 1.88 6 0.08 2.01 6 0.10
Impropers (°) 0.14 6 0.03 0.11 6 0.03
Energies (kcal mol21)
ENOE 0.53 6 0.58 2.08 6 1.60
Ecdih 0.022 6 0.038 0.056 6 0.074
EL-J 294.1 6 11.4 2121.4 6 13.9
Ebond 1 Eangle 1 Eimproper 29.6 6 2.9 41.6 6 4.5
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criterion stated above, using 255 distance restraints (91 intra-
residual, 89 sequential, and 75 medium range) and 19 dihedral
restraints. The deviations from ideal geometry and from exper-
imental restraints are given in Table I, together with backbone
pairwise RMSD values. These are lower than for con-G, reflect-
ing the greater number of distance restraints per residue used
in the calculations. Again, the pairwise RMSD values are sub-
stantially lower when the N terminus, middle segment, and C
terminus are treated separately. These regions are shown su-
perimposed in Fig. 9. The backbone angular order parameters
(Fig. 7B) are consistently high for residues 2–21, which all lie in
the a-region of the Ramachandran plot. The backbone RMSD
values (Fig. 7B) are lowest for residues 4–9 and 16–18. The
central region 10–14 of the peptide has elevated RMSD values,
most likely due to some flexibility in this region. Similar to
con-G, most of the helices are nonlinear, with the degree of
curvature varying significantly. H-bond analysis again indi-
cates that a mixture of 310 and a-helix is present, with the 310
helix component representing approximately 30% of the total
measured backbone H-bonds.
DISCUSSION
Divalent Cation Concentration—The CD spectra of both
con-G and con-T shown in Fig. 1, A and B, indicate that these
peptides are strongly helical in the presence of Ca21. The most
striking observation is that con-T is extremely helical, even in
the absence of Ca21, which may be explained by the relative
positions of the Gla residues (see below). The EDTA titrations
showed that some of the Ca21 ions are bound very tightly to
con-G, even when the EDTA concentration is increased to four
times the concentration of CaCl2. At these relative concentra-
tions, the peptide still exhibits residual Ca21-induced stabili-
zation. EDTA did not reduce the helical content below that
induced by 3.0 mM CaCl2. This shows that Ca
21, in some
instances, is bound more tightly to con-G than to EDTA.
Potassium ions did not stabilize the peptides (Fig. 1, C and
D), due to their different ionic properties relative to Ca21. Of
the divalent cations, Mg21 and Zn21 provided the greatest
stabilization to the structure of con-G.
Comparison of the Structures of Con-G and Con-T—The re-
sults have shown that con-G and con-T both adopt stable hel-
ices over their entire length, although the conditions required
to achieve this are slightly different. The three-dimensional
structures of both peptides show that although each residue is
well defined locally, there are a range of global orientations
that agree with the experimental restraints. A superimposition
of con-G curved and linear structures with corresponding struc-
tures of con-T (Fig. 10A) emphasizes a striking degree of sim-
ilarity. A surface representation of a typical curved structure
for each of con-G and con-T in identical orientations in Fig. 10B
shows the hydrophilic residues, at least from residues 3 to 13,
are on the exterior surface and the hydrophobic residues are on
the inner (more concave) surface, a phenomenon which is a
characteristic feature of amphipathic helices in solution. The
hydrophobic face of both peptides are alike, being composed of
a mixture of polar and hydrophobic side chains. Characteristic
of amphipathic helices, the hydrophilic face of con-T consists of
alternating regions of positive and negative charge, however,
that of con-G is unusual in that it consists almost entirely of
negative charge. Presumably, the binding of divalent cations to
this region of con-G stabilizes a conformational state that
would otherwise be unfavorable electrostatically. In contrast,
con-T does not require Ca21 to adopt the same conformation,
although it does not necessarily follow that Gla side chains in
this peptide do not bind to divalent cations.
The three-dimensional structures of con-G and con-T are
FIG. 7. Backbone angular order parameters for con-G (top
panel) and con-T (lower panel). The backbone angular order param-
eters for A, con-G showing: S(f) (shaded) and S(c) (outline) and back-
bone RMSD versus residue number; and B, for con-T showing the
backbone angular order parameters S(f) (shaded) and S(c) (outline)
and backbone RMSD versus residue number.
FIG. 8. The 18 low energy structures
of con-G showing superimpositions
over residues 6–14 (left), 2–9 (middle),
and 11–16 (right). Shown in green rib-
bon are three different low energy struc-
tures that represent con-G.
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composed of a dynamic mixture of 310 and a-helix. Although
theoretical studies on the relative energies of 310 versus a-helix
suggest that the latter conformation is preferred in helices of
greater than 10–12 residues due to a lower degree of steric
hindrance (35, 36), this is offset in con-T by a large number of
putative electrostatic i,i13 interactions which would favor 310
helix formation. For example, helix stabilizing salt-bridges may
be formed between Gla4-Lys7, Lys7-Gla10, Gla10-Arg13, Arg13-
Glu16, and Glu16-Lys19 in the 310 conformation, but only be-
tween Gla3-Lys7 and Gla14-Lys18 in a-helix. Furthermore, in
the a-helical conformation, the Gla10-Gla14 interaction would
be disruptive. The same argument may be applied to con-G to
explain why it is less helical in the absence of divalent cations.
The electrostatic repulsion of the side chains of Gla3-Gla7,
Gla4-Gla7, Gla7-Gla10, and Gla10-Gla14 would hinder both 310
and a-helical conformations. However, the presence of Ca21
could promote the alignment of Gla residues so that the above
mentioned interactions become favorable.
Comparison with Previous Reports on Conantokin Struc-
tures—This is the first published report on the three-dimen-
sional structure of con-G and con-T, however, there have been
previous CD spectroscopic studies of both peptides (4, 7). Zhou
et al. (7) suggest that con-G adopts a highly characteristic helix
with a rigid middle segment and mobile N- and C-terminal
ends. They propose that the middle segment may function as a
helical spacer between the two flexible terminal domains that
may bind to two separate sites on the NMDA receptor (7). This
suggestion may be regarded as tentative, as CD spectroscopy
does not provide structural information in a sequence specific
manner. The NMR data presented here provides sequence spe-
cific structural information and shows that the helix extends
from the N to the C terminus. In addition, the helical region is
not necessarily rigid, even in the middle segment, but may
have considerable flexibility arising from a-helix to 310-helix
transitions. This a7310 interchange was also proposed by Zhou
et al. (7) on the basis of their CD studies of con-G analogues
with specific Gla3 Ala, Gla3 Ser, or Gla3 phospho-Ser (310
helix inducing) substitutions.
Role of Divalent Cations—Of significant importance is the
role divalent cations play in structure-activity relationships for
the conantokins. In the case of con-G, we find there is a struc-
tural dependence on divalent cation concentration, however,
this is not consistent with the recent findings of Chandler et al.
(4) and Zhou et al. (7). In both these earlier studies, the helix
content determined by CD spectroscopy for con-G in the ab-
sence of added Ca21 is approximately equivalent to that calcu-
lated here for the peptide in the presence of excess Ca21. This
strongly suggests that some Ca21, or perhaps another divalent
cation, was already bound to con-G prior to the addition of
Ca21. Indeed, our experiments with EDTA show that Ca21
bound to con-G is difficult to remove. Considering this and also
the range of divalent cations which have been shown here to
affect the stability of the con-G structure, the validity of recent
activity experiments performed in the “nominal” absence of
Ca21 are open to question (6). The role of the divalent cations
FIG. 9. The 17 low energy structures
of con-T showing superimpositions
over residues 6–14 (left), 2–10 (mid-
dle), and 11–20 (right). Shown in pink
ribbon are three different low energy
structures that represent con-T.
FIG. 10. A, backbone superimpositons of two low energy structures of
con-G (green) and con-T (pink) over residues 2–14 representing curved
(left) and linear (right) helices; and B, surface views of low energy
structures of con-G (green) and con-T (pink). Color coding is as follows:
positively charged residues, blue; negatively charged residues, red;
polar residues, green; hydrophobic residues, yellow. Although the local
geometry of the side chains are not well defined, their relative positions
are similar in each of the structures.
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seems more problematic by the finding that the structure of
con-T does not appear to be affected by the addition of Ca21.
However, the lack of structural stabilization does not exclude
divalent cations from binding to the Gla side chains. Further-
more, it raises questions on the biological reasons for predom-
inance of these post-translationally modified residues, two
(Gla3 and Gla4) of which have been shown to be important to
the activity of these peptides (7). Since it has been demon-
strated here that con-T and con-G are able to adopt the same
three-dimensional structure, it is possible that the former pep-
tide is able to adopt its biologically active conformation in the
absence of divalent cations, but it requires their presence for
activity.
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